{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:57:31Z","timestamp":1789073851262,"version":"build-2803163510"},"reference-count":34,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2019.0607","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T10:09:36Z","timestamp":1568023776000},"source":"Crossref","is-referenced-by-count":14,"title":["Problematic Medication With Benzodiazepines, \u201cZ-drugs\u201d, and Opioid Analgesics"],"prefix":"10.3238","author":[{"given":"Sven","family":"Buth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Holzbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus-Sebastian","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Neumann-Runde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ommo","family":"Meiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Verthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"10.3238\/arztebl.2019.0607_ref1","unstructured":"Glaeske G, Hoffmann F: Medikamente \u2013 Psychotrope und andere Arzneimittel mit Missbrauchs- und Abh\u00e4ngigkeitspotenzial. In: Deutsche Hauptstelle f\u00fcr Suchtfragen, ed.: Jahrbuch Sucht 2014. Lengerich: Pabst Science Publishers 2014."},{"key":"10.3238\/arztebl.2019.0607_ref2","doi-asserted-by":"crossref","unstructured":"Gomes de Matos E, Atzendorf J, Kraus L, Piontek D: Substanzkonsum in der Allgemeinbev\u00f6lkerung in Deutschland. SUCHT 2016; 62: 271\u201381","DOI":"10.1024\/0939-5911\/a000445"},{"key":"10.3238\/arztebl.2019.0607_ref3","doi-asserted-by":"crossref","unstructured":"Pabst A, Kraus L, Gomes de Matos E, Piontek D: Substanzkonsum und substanzbezogene St\u00f6rungen in Deutschland im Jahr 2012. SUCHT 2013; 59: 321\u201331","DOI":"10.1024\/0939-5911.a000275"},{"key":"10.3238\/arztebl.2019.0607_ref4","doi-asserted-by":"crossref","unstructured":"Buth S, Holzbach R, Rosenkranz M, Verthein U: Der Gebrauch von Medikamenten mit Abh\u00e4ngigkeitspotenzial in Deutschland. Eine prospektive Analyse kassen\u00e4rztlicher Verschreibungen der Jahre 2006 bis 2010. Bundesgesundheitsblatt 2017; 60: 865\u201372","DOI":"10.1007\/s00103-017-2571-4"},{"key":"10.3238\/arztebl.2019.0607_ref5","doi-asserted-by":"crossref","unstructured":"Verthein U, Holzbach R, Martens MS, Buth S: Langzeitverordnungen von Benzodiazepinen und Z-Substanzen \u2013 deskriptive Analysen \u00fcber einen 3-j\u00e4hrigen Zeitraum. Suchttherapie 2018; 19: 99\u2013106","DOI":"10.1055\/s-0043-109361"},{"key":"10.3238\/arztebl.2019.0607_ref6","doi-asserted-by":"crossref","unstructured":"Xing D, Ma XL, Ma JX, Wang J, Yang Y, Chen Y: Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int 2014; 25: 105\u201320","DOI":"10.1007\/s00198-013-2446-y"},{"key":"10.3238\/arztebl.2019.0607_ref7","doi-asserted-by":"crossref","unstructured":"Bakken M, Engeland A, Enges\u00e6ter L, Ranhoff A, Hunskaar S, Ruths S: Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 2014; 70: 873\u201380","DOI":"10.1007\/s00228-014-1684-z"},{"key":"10.3238\/arztebl.2019.0607_ref8","doi-asserted-by":"crossref","unstructured":"Chen TY, Winkelman JW, Mao W-C, Liu CL, Hsu CY, Wu CS: The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia. CHEST 2018; 153: 161\u201371","DOI":"10.1016\/j.chest.2017.07.030"},{"key":"10.3238\/arztebl.2019.0607_ref9","doi-asserted-by":"crossref","unstructured":"Islam MM, Iqbal U, Walther B, et al.: Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis. Neuroepidemiology 2016; 47: 181\u201391","DOI":"10.1159\/000454881"},{"key":"10.3238\/arztebl.2019.0607_ref10","doi-asserted-by":"crossref","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN: Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015; 156: 569\u201376","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"10.3238\/arztebl.2019.0607_ref11","doi-asserted-by":"crossref","unstructured":"Helmerhorst GTT, Teunis T, Janssen SJ, Ring D: An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and canada. Bone Joint J 2017; 99-B: 856\u201364","DOI":"10.1302\/0301-620X.99B7.BJJ-2016-1350.R1"},{"key":"10.3238\/arztebl.2019.0607_ref12","doi-asserted-by":"crossref","unstructured":"Schwabe U, Paffrath D, Ludwig WD, Klauber J: Arzneiverordnungs-Report 2017. Berlin, Heidelberg: Springer Verlag 2017","DOI":"10.1007\/978-3-662-54630-7"},{"key":"10.3238\/arztebl.2019.0607_ref13","unstructured":"Schubert I, Ihle P, Sabatowski R: Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010: Eine Studie auf der Basis von Krankenkassendaten. Dtsch Arztebl 2013; 110: 45\u201351"},{"key":"10.3238\/arztebl.2019.0607_ref14","doi-asserted-by":"crossref","unstructured":"H\u00e4user W, Bock F, Engeser P, T\u00f6lle T, Willweber-Strumpf A, Petzke F: Clinical practice guideline: long-term opioid use in non-cancer pain. Dtsch Arztebl Int 2014; 111: 732\u201340","DOI":"10.3238\/arztebl.2014.0732"},{"key":"10.3238\/arztebl.2019.0607_ref15","doi-asserted-by":"crossref","unstructured":"Els C, Jackson TD, Kunyk D, et al.: Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10: CD012509","DOI":"10.1002\/14651858.CD012509"},{"key":"10.3238\/arztebl.2019.0607_ref16","doi-asserted-by":"crossref","unstructured":"Marschall U, L\u2018Hoest H, Radbruch L, Hauser W: Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain 2016; 20: 767\u201376","DOI":"10.1002\/ejp.802"},{"key":"10.3238\/arztebl.2019.0607_ref17","unstructured":"Bundesministerium f\u00fcr Gesundheit: GKV-Versicherte nach Alter und Wohnort. GKV-Statistik KM6. 2006\u20132016."},{"key":"10.3238\/arztebl.2019.0607_ref18","unstructured":"GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WIdO): Das anatomisch-therapeutisch-chemische Klassifikationssystem mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben f\u00fcr Deutschland im Jahre 2016. Berlin 2016."},{"key":"10.3238\/arztebl.2019.0607_ref19","unstructured":"IBM: IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY 2017."},{"key":"10.3238\/arztebl.2019.0607_ref20","doi-asserted-by":"crossref","unstructured":"Nurminen J, Puustinen J, L\u00e4hteenm\u00e4ki R, et al.: Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC Geriatr 2014; 14: 121","DOI":"10.1186\/1471-2318-14-121"},{"key":"10.3238\/arztebl.2019.0607_ref21","doi-asserted-by":"crossref","unstructured":"Khong TP, de Vries F, Goldenberg JSB, et al.: Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int 2012; 91: 24\u201331","DOI":"10.1007\/s00223-012-9603-8"},{"key":"10.3238\/arztebl.2019.0607_ref22","doi-asserted-by":"crossref","unstructured":"Hoffmann F: Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs. Swiss Med Wkly 2013; 143: w13745","DOI":"10.4414\/smw.2013.13745"},{"key":"10.3238\/arztebl.2019.0607_ref23","doi-asserted-by":"crossref","unstructured":"Yen CF, Yen CN, Ko CH, et al.: Correlates of dependence and beliefs about the use of hypnotics among Zolpidem and Zopiclone users. Subst Use Misuse 2015; 50: 350\u20137","DOI":"10.3109\/10826084.2014.980955"},{"key":"10.3238\/arztebl.2019.0607_ref24","doi-asserted-by":"crossref","unstructured":"Victorri-Vigneau C, G\u00e9rardin M, Rousselet M, Guerlais M, Grall-Bronnec M, Jolliet P: An update on Zolpidem abuse and dependence. J Addict Dis 2014; 33: 15\u201323","DOI":"10.1080\/10550887.2014.882725"},{"key":"10.3238\/arztebl.2019.0607_ref25","doi-asserted-by":"crossref","unstructured":"Rousselet M, Feuillet F, Gerardin M, Jolliet P, Hardouin JB, Victorri-Vigneau C: The french addictovigilance network clinical assessment: Z-drugs, true false twins. Expert Opin Drug Saf 2017; 16: 1063\u20139","DOI":"10.1080\/14740338.2017.1346084"},{"key":"10.3238\/arztebl.2019.0607_ref26","doi-asserted-by":"crossref","unstructured":"Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I: Z-drugs and risk for falls and fractures in older adults\u2014a systematic review and meta-analysis. Age Ageing 2018; 47: 201\u20138","DOI":"10.1093\/ageing\/afx167"},{"key":"10.3238\/arztebl.2019.0607_ref27","doi-asserted-by":"crossref","unstructured":"Olfson M, King M, Schoenbaum M: Benzodiazepine use in the United States. JAMA Psychiatry 2015; 72: 136\u201342","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"10.3238\/arztebl.2019.0607_ref28","doi-asserted-by":"crossref","unstructured":"Martinsson G, Fagerberg I, Wiklund-Gustin L, Lindholm C: Specialist prescribing of psychotropic drugs to older persons in Sweden\u2014a register-based study of 188 024 older persons. BMC Psychiatry 2012; 12: 197","DOI":"10.1186\/1471-244X-12-197"},{"key":"10.3238\/arztebl.2019.0607_ref29","doi-asserted-by":"crossref","unstructured":"Rudd RA, Seth P, David F, Scholl L: Increases in drug and opioid-involved overdose deaths \u2013 United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep 2016; 65: 1445\u201352","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"10.3238\/arztebl.2019.0607_ref30","doi-asserted-by":"crossref","unstructured":"White ND: Opioid abuse and overdose: prevention strategies. Am J Lifestyle Med 2015; 9: 412\u20135","DOI":"10.1177\/1559827615598527"},{"key":"10.3238\/arztebl.2019.0607_ref31","doi-asserted-by":"crossref","unstructured":"Compton WM, Boyle M, Wargo E: Prescription opioid abuse: Problems and responses. Prev Med 2015; 80: 5\u20139","DOI":"10.1016\/j.ypmed.2015.04.003"},{"key":"10.3238\/arztebl.2019.0607_ref32","doi-asserted-by":"crossref","unstructured":"Holzbach R, Martens M, Kalke J, Raschke P: Zusammenhang zwischen Verschreibungsverhalten der \u00c4rzte und Medikamentenabh\u00e4ngigkeit ihrer Patienten. Bundesgesundheitsbl 2010; 53: 319\u201325","DOI":"10.1007\/s00103-010-1029-8"},{"key":"10.3238\/arztebl.2019.0607_ref33","doi-asserted-by":"crossref","unstructured":"Hoffmann F, Glaeske G: Benzodiazepinhypnotika, Zolpidem und Zopiclon auf Privatrezept. Nervenarzt 2014: 1\u20137","DOI":"10.1007\/s00115-014-4016-8"},{"key":"10.3238\/arztebl.2019.0607_ref34","doi-asserted-by":"crossref","unstructured":"Knopf H, Grams D: Arzneimittelanwendung von Erwachsenen in Deutschland. Bundesgesundheitsblatt 2013; 56: 868\u201377.","DOI":"10.1007\/s00103-013-1667-8"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T10:22:35Z","timestamp":1638786155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2019.0607","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]}}}